Characteristics associated with early vs. late adoption of lung cancer screening.

Autor:	Shusted CS; The Jane and Leonard Korman Respiratory Institute, Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA., Eberth JM; Dornsife School Of Public Health, Department of Health Management and Policy, Drexel University, Philadelphia, PA, USA., Juon HS; Division of Population Science, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Barta JA; The Jane and Leonard Korman Respiratory Institute, Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Jazyk:	angličtina
Zdroj:	Preventive medicine reports [Prev Med Rep] 2024 Jul 07; Vol. 44, pp. 102820. Date of Electronic Publication: 2024 Jul 07 (Print Publication: 2024).
DOI:	10.1016/j.pmedr.2024.102820
Abstrakt:	Background: Although lung cancer screening (LCS) reduces lung cancer mortality among high-risk individuals, uptake overall remains low. With all cancer screening modalities, a period of diffusion among medical providers and the public is expected, with screening uptake exhibiting a distribution among early vs. late adoption. We aimed to characterize individuals undergoing LCS based upon the timeframe of screening adoption. Methods: This retrospective study examined patients who underwent LCS between January 2015 - December 2022 in a centralized LCS program. Based on United States Preventive Services Task Force (USPSTF) criteria for LCS, early and late adopters of LCS - defined by time from eligibility to screening completion - were compared. A multivariable regression model was constructed to identify factors associated with early adoption of LCS. Results: Among patients screened during the study period, 90.4% were eligible based on USPSTF 2013 criteria, and 9.6% were eligible based on USPSTF 2021 criteria. Of the USPSTF 2013 eligible persons, multivariable analysis demonstrated Black/African-American individuals and current smokers had significantly greater odds of early adoption (aOR 1.428 and 1.514, respectively). Those without a family history of lung cancer or without a personal history of cancer had significantly lower odds of early adoption of LCS. Conclusions: Early adopters were more likely to report Black/African-American race or current smoking status after adjustment for covariates. Future research should examine how screening diffuses across the overall LCS-eligible population, as well as identify factors that drive and inhibit diffusion to create programs and policies with the ultimate goal of increasing timely LCS uptake. Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JAB reports research grants from the Genentech Health Equity Innovations Fund and fees paid to her institution from Delfi Diagnostics, Inc. (© 2024 The Authors. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu